Activated platelet-rich plasma improves adipose-derived stem cell transplantation efficiency in injured articular cartilage

Stem Cell Research and Therapy

Volumn 4, Issue 4, 2013, Pages

  Van Pham, Phuc ^a   Bui, Khanh Hong Thien ^b   Ngo, Dat Quoc ^b   Vu, Ngoc Bich ^a   Truong, Nhung Hai ^a   Phan, Nhan Lu Chinh ^a   Le, Dung Minh ^a   Duong, Triet Dinh ^b   Nguyen, Thanh Duc ^b   Le, Vien Tuong ^b   Phan, Ngoc Kim ^a  

^a UNIVERSITY OF NATURAL SCIENCES   (Viet Nam)

^b UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

Author keywords

Adipose tissue derived stem cells; Articular cartilage injury; Joint failure; Mesenchymal stem cells; Osteoarthritis; Platelet rich plasma

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CARTILAGE INJURY; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HEALING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; THROMBOCYTE RICH PLASMA; ADIPOSE TISSUE; ANIMAL; ARTICULAR CARTILAGE; CYTOLOGY; IMMUNOPHENOTYPING; METABOLISM; PROCEDURES; REGENERATION; TISSUE ENGINEERING;

MURINAE;

ADIPOSE TISSUE; ANIMALS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; HUMANS; IMMUNOPHENOTYPING; MICE; PLATELET-RICH PLASMA; REGENERATION; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84880933327     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt277     Document Type: Article

References (65)

1. Platelet-rich plasma in muscle healing. Borrione P, Gianfrancesco AD, Pereira MT, Pigozzi F, Am J Phys Med Rehabil 2010 89 854 861 10.1097/PHM.0b013e3181f1c1c7 20855985
2. Platelet-rich plasma: a promising product for treatment of peripheral nerve regeneration after nerve injury. Yu W, Wang J, Yin J, Int J Neurosci 2011 121 176 180 10.3109/00207454.2010.544432 21244302
3. Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast. Kim DH, Je YJ, Kim CD, Lee YH, Seo YJ, Lee JH, Lee Y, Ann Dermatol 2011 23 424 431 10.5021/ad.2011.23.4.424 22148008
4. Platelet-rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase-1 in human skin fibroblasts. Cho JW, Kim SA, Lee KS, Int J Mol Med 2012 29 32 36 21964487
5. The effects of intra-articular platelet-rich plasma injection according to the severity of collagenase-induced knee osteoarthritis in a rabbit model. Kwon DR, Park GY, Lee SU, Ann Rehabil Med 2012 36 458 465 10.5535/arm.2012.36.4. 458 22977770
6. Intraarticular injection of platelet-rich plasma reduces inflammation in a pig model of rheumatoid arthritis of the knee joint. Lippross S, Moeller B, Haas H, Tohidnezhad M, Steubesand N, Wruck CJ, Kurz B, Seekamp A, Pufe T, Varoga D, Arthritis Rheum 2011 63 3344 3353 10.1002/art.30547 21769848
7. Cartilage repair in the knee with subchondral drilling augmented with a platelet-rich plasma-immersed polymer-based implant. Siclari A, Mascaro G, Gentili C, Kaps C, Cancedda R, Boux E, Knee Surg Sports Traumatol Arthrosc 2013 Epub ahead of print
8. Is platelet-rich plasma able to enhance the results of arthroscopic microfracture in early osteoarthritis and cartilage lesion over 40 years of age? Lee GW, Son JH, Kim JD, Jung GH, Eur J Orthop Surg Traumatol 2013 23 581 587 10.1007/s00590-012-1038-4 23412171
9. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Jang SJ, Kim JD, Cha SS, Eur J Orthop Surg Traumatol 2013 23 573 580 10.1007/s00590-012-1037-5 23412170
10. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A, Am J Sports Med 2013 41 356 364 10.1177/0363546512471299 23299850
11. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Spakova T, Rosocha J, Lacko M, Harvanova D, Gharaibeh A, Am J Phys Med Rehabil 2012 91 411 417 10.1097/PHM.0b013e3182aab72 22513879
12. Multilineage cells from human adipose tissue: implications for cell-based therapies. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH, Tissue Eng 2001 7 211 228 10.1089/107632701300062859 11304456
13. Mesenchymal markers on human adipose stem/progenitor cells. Zimmerlin L, Donnenberg VS, Rubin JP, Donnenberg AD, Cytometry A 2013 83 134 140 23184564
14. The comparison of multilineage differentiation of bone marrow and adipose-derived mesenchymal stem cells. Zhu X, Du J, Liu G, Clin Lab 2012 58 897 903 23163104
15. Characterization of human adipose-derived stem cells. Gaiba S, Franca LP, Franca JP, Ferreira LM, Acta Cir Bras 2012 27 471 476 10.1590/S0102- 86502012000700007 22760832
16. Fat pad-derived mesenchymal stem cells as a potential source for cell-based adipose tissue repair strategies. Khan WS, Adesida AB, Tew SR, Longo UG, Hardingham TE, Cell Prolif 2012 45 111 120 10.1111/j.1365-2184.2011.00804.x 22260253
17. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statemen. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606
18. Comparative evaluation of human mesenchymal stem cells of fetal (Wharton's jelly) and adult (adipose tissue) origin during prolonged in vitro expansion: considerations for cytotherapy. Christodoulou I, Kolisis FN, Papaevangeliou D, Zoumpourlis V, Stem Cells Int 2013 2013 246134 23533440
19. Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function. Harn HJ, Lin SZ, Hung SH, Subeq YM, Li YS, Syu WS, Ding DC, Lee RP, Hsieh DK, Lin PC, Chiou TW, Cell Transplant 2012 21 2753 2764 10.3727/096368912X652959 22776464
20. Transplantation of adipose derived stem cells for peripheral nerve regeneration in sciatic nerve defects of the rat. Gu JH, Ji YH, Dhong ES, Kim DH, Yoon ES, Curr Stem Cell Res Ther 2012 7 347 355 10.2174/157488812802481463 22563658
21. Transplantation of adipose-derived stem cells for peripheral nerve repair. Liu G, Cheng Y, Guo S, Feng Y, Li Q, Jia H, Wang Y, Tong L, Tong X, Int J Mol Med 2011 28 565 572 21687931
22. Delivery of adipose-derived precursor cells for peripheral nerve repair. Santiago LY, Clavijo-Alvarez J, Brayfield C, Rubin JP, Marra KG, Cell Transplant 2009 18 145 158 10.3727/096368909788341289 19499703
23. Treatment of reperfused ischemia with adipose-derived stem cells in a preclinical Swine model of myocardial infarction. Mazo M, Hernández S, Gavira JJ, Abizanda G, Araña M, López-Martínez T, Moreno C, Merino J, Martino-Rodríguez A, Uixeira A, García de Jalón JA, Pastrana J, Martínez-Caro D, Prósper F, Cell Transplant 2012 21 2723 2733 10.3727/096368912X638847 22524986
24. Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration. Rigol M, Solanes N, Farré J, Roura S, Roqué M, Berruezo A, Bellera N, Novensà L, Tamborero D, Prat-Vidal C, Huzman MA, Batlle M, Hoefsloot M, Sitges M, Ramírez J, Dantas AP, Merino A, Sanz G, Brugada J, Bayés- Genís A, Heras M, J Card Fail 2010 16 357 366 10.1016/j.cardfail.2009.12. 006 20350704
25. Adipose-derived stem-cell treatment of skeletal muscle injury. Pecanha R, Bagno LL, Ribeiro MB, Robottom Ferreira AB, Moraes MO, Zapata-Sudo G, Kasai-Brunswick TH, Campos-de-Carvalho AC, Goldenberg RC, Saar Werneck-de-Castro JP, J Bone Joint Surg Am 2012 94 609 617 10.2106/JBJS.K.00351 22488617
26. Transplantation of adipose-derived mesenchymal stem cells into a murine model of passive chronic immune thrombocytopenia. Xiao J, Zhang C, Zhang Y, Zhang X, Zhao J, Liang J, Zhong X, Chen Y, Transfusion 2012 52 2551 2558 10.1111/j.1537-2995.2012.03642.x 22486546
27. Transplantation of adipose tissue-derived stem cells overexpressing heme oxygenase-1 improves functions and remodeling of infarcted myocardium in rabbits. Yang JJ, Yang X, Liu ZQ, Hu SY, Du ZY, Feng LL, Liu JF, Chen YD, Tohoku J Exp Med 2012 226 231 241 10.1620/tjem.226.231 22450704
28. Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. Riordan NH, Ichim TE, Min WP, Wang H, Solano F, Lara F, Alfaro M, Rodriguez JP, Harman RJ, Patel AN, Murphy MP, Lee RR, Minev B, J Transl Med 2009 7 29 10.1186/1479-5876-7-29 19393041
29. Human adipose-derived stem cells for cell-based therapies in the treatment of systemic sclerosis. Scuderi N, Ceccarelli S, Onesti MG, Fioramonti P, Guidi C, Romano F, Frati L, Angeloni A, Marchese C, Cell Transplant 2013 22 779 795 10.3727/096368912X639017 22526170
30. Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Black LL, Gaynor J, Adams C, Dhupa S, Sams AE, Taylor R, Harman S, Gingerich DA, Harman R, Vet Ther 2008 9 192 200 19003780
31. Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Black LL, Gaynor J, Gahring D, Adams C, Aron D, Harman S, Gingerich DA, Harman R, Vet Ther 2007 8 272 284 18183546
32. Production of canine mesenchymal stem cells from adipose tissue and their application in dogs with chronic osteoarthritis of the humeroradial joints. Guercio A, Di Marco P, Casella S, Cannella V, Russotto L, Purpari G, Di Bella S, Piccione G, Cell Biol Int 2012 36 189 194 10.1042/CBI20110304 21936851
33. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Toghraie FS, Chenari N, Gholipour MA, Faghih Z, Torabinejad S, Dehghani S, Ghaderi A, Knee 2011 18 71 75 10.1016/j.knee.2010. 03.001 20591677
34. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. Frisbie DD, Kisiday JD, Kawcak CE, Werpy NM, McIlwraith CW, J Orthop Res 2009 27 1675 1680 10.1002/jor.20933 19544397
35. SOX trio-co-transduced adipose stem cells in fibrin gel to enhance cartilage repair and delay the progression of osteoarthritis in the rat. Lee JM, Im GI, Biomaterials 2012 33 2016 2024 10.1016/j.biomaterials.2011.11.050 22189147
36. A single injection of adipose-derived stem cells protects against cartilage damage and lowers synovial activation in experimental osteoarthritis. ter Huurne MC, van Lent PLEM, Blom AB, Blattes R, Jeanson Y, Casteilla L, Jorgensen C, Arthritis Rheum 2011 63 1784
37. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. ter Huurne M, Schelbergen R, Blattes R, Blom A, de Munter W, Grevers LC, Jeanson J, Noël D, Casteilla L, Jorgensen C, van den Berg W, van Lent PL, Arthritis Rheum 2012 64 3604 3613 10.1002/art.34626 22961401
38. Transplantation of nonexpanded adipose stromal vascular fraction and platelet-rich plasma for articular cartilage injury treatment in mice model. Van Pham P, Hong-Thien Bui K, Quoc Ngo D, Tan Khuat L, Kim Phan N, J Med Eng 2013 2013 7
39. Stem cell therapy in a caprine model of osteoarthritis. Murphy JM, Fink DJ, Hunziker EB, Barry FP, Arthritis Rheum 2003 48 3464 3474 10.1002/art.11365 14673997
40. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Xie X, Wang Y, Zhao C, Guo S, Liu S, Jia W, Tuan RS, Zhang C, Biomaterials 2012 33 7008 7018 10.1016/j.biomaterials.2012.06.058 22818985
41. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. Pak J, J Med Case Rep 2011 5 296 10.1186/1752-1947-5-296 21736710
42. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Koh YG, Jo SB, Kwon OR, Suh DS, Lee SW, Park SH, Choi YJ, Arthroscopy 2013 29 748 755 10.1016/j.arthro.2012.11.017 23375182
43. Adipose stem cells can secrete angiogenic factors that inhibit hyaline cartilage regeneration. Lee CS, Burnsed OA, Raghuram V, Kalisvaart J, Boyan BD, Schwartz Z, Stem Cell Res Ther 2012 3 35 10.1186/scrt126 22920724
44. Differentiating of banked human umbilical cord blood-derived mesenchymal stem cells into insulin-secreting cells. Phuc PV, Nhung TH, Loan DT, Chung DC, Ngoc PK, In Vitro Cell Dev Biol Anim 2011 47 54 63 10.1007/s11626-010-9356-5 21082287
45. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Martin I, Jakob M, Schafer D, Dick W, Spagnoli G, Heberer M, Osteoarthr Cartil 2001 9 112 118 10.1053/joca.2000.0366 11237658
46. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Li Y, Tew SR, Russell AM, Gonzalez KR, Hardingham TE, Hawkins RE, Tissue Eng 2004 10 575 584 10.1089/107632704323061933 15165474
47. Can activated platelet rich plasma combined with adipose-derived stem cells be used to treat skin wrinkles? a mechanism study. Van Pham P, Dang LT-T, Truong NH, Phan NK, Medical Advancements in Aging and Regenerative Technologies: Clinical Tools and Applications Germany: IGI Global 2013 313 329
48. Effects of medium supplements on proliferation, differentiation potential, and in vitro expansion of mesenchymal stem cells. Gharibi B, Hughes FJ, Stem Cells Transl Med 2012 1 771 782 10.5966/sctm.2010-0031 23197689
49. Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue. Chieregato K, Castegnaro S, Madeo D, Astori G, Pegoraro M, Rodeghiero F, Cytotherapy 2011 13 933 943 10.3109/14653249.2011.583232 21623669
50. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Kocaoemer A, Kern S, Kluter H, Bieback K, Stem Cells 2007 25 1270 1278 10.1634/stemcells.2006-0627 17255520
51. Effect of platelet-rich plasma on the proliferation and adipogenic differentiation of human adipose-derived stem cells in vitro. Zhang YS, He JH, Xiao GY, Li QM, Nan Fang Yi Ke Da Xue Xue Bao 2011 31 525 528 21421498
52. Experimental research of the promotion effect of autogeneic PRP on osteogenic differentiation of human adipose-derived stem cells in vitro. Li H, Liu D, Yu Y, Wu T, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2009 23 732 736 19594024
53. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo FZ, Kusumoto K, Plast Reconstr Surg 2008 122 1352 1360 10.1097/PRS.0b013e3181882046 18971718
54. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Pfander D, Kortje D, Zimmermann R, Weseloh G, Kirsch T, Gesslein M, Cramer T, Swoboda B, Ann Rheum Dis 2001 60 1070 1073 10.1136/ard.60.11.1070 11602483
55. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Enomoto H, Inoki I, Komiya K, Shiomi T, Ikeda E, Obata K, Matsumoto H, Toyama Y, Okada Y, Am J Pathol 2003 162 171 181 10.1016/S0002-9440(10)63808-4 12507900
56. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. Pufe T, Harde V, Petersen W, Goldring MB, Tillmann B, Mentlein R, J Pathol 2004 202 367 374 10.1002/path.1527 14991903
57. The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair. Mifune Y, Matsumoto T, Takayama K, Ota S, Li H, Meszaros LB, Usas A, Nagamune K, Gharaibeh B, Fu FH, Huard J, Osteoarthr Cartil 2013 21 175 185 10.1016/j.joca.2012.09.018 23041435
58. Platelet-rich plasma increases matrix metalloproteinases in cultures of human synovial fibroblasts. Browning SR, Weiser AM, Woolf N, Golish SR, SanGiovanni TP, Scuderi GJ, Carballo C, Hanna LS, J Bone Joint Surg Am 2012 94 1721 e1727 10.2106/JBJS.L.00620 23224392
59. Fibroblast growth factor 2 enhances the kinetics of mesenchymal stem cell chondrogenesis. Cheng T, Yang C, Weber N, Kim HT, Kuo AC, Biochem Biophys Res Commun 2012 426 544 550 10.1016/j.bbrc.2012.08.124 22982316
60. Effects of FGF-2 on human adipose tissue derived adult stem cells morphology and chondrogenesis enhancement in Transwell culture. Kabiri A, Esfandiari E, Hashemibeni B, Kazemi M, Mardani M, Esmaeili A, Biochem Biophys Res Commun 2012 424 234 238 10.1016/j.bbrc.2012.06.082 22728881
61. Expansion in the presence of FGF-2 enhances the functional development of cartilaginous tissues engineered using infrapatellar fat pad derived MSCs. Buckley CT, Kelly DJ, J Mech Behav Biomed Mater 2012 11 102 111 22658159
62. Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. Stewart AA, Byron CR, Pondenis H, Stewart MC, Am J Vet Res 2007 68 941 945 10.2460/ajvr.68.9.941 17764407
63. Enhanced chondrogenic marker expression of human mesenchymal stem cells by interaction with both TGF-β3 and hyaluronic acid. Bhang SH, Jeon JY, La WG, Seong JY, Hwang JW, Ryu SE, Kim BS, Biotechnol Appl Biochem 2011 58 271 276 10.1002/bab.39 21838802
64. Gelatin microspheres containing TGF-beta3 enhance the chondrogenesis of mesenchymal stem cells in modified pellet culture. Fan H, Zhang C, Li J, Bi L, Qin L, Wu H, Hu Y, Biomacromolecules 2008 9 927 934 10.1021/bm7013203 18269244
65. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Koh YG, Choi YJ, Knee 2012 19 902 907 10.1016/j.knee.2012.04.001 22583627